Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit

Environmental Health Perspectives

Volumn 115, Issue 3, 2007, Pages 354-360

  Beyer, April J ^a   Wang, Kan ^a   Umble, Amber N ^a   Wolt, Jeffrey D ^a   Cunnick, Joan E ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Adulterated food; Genetically modified organism; Heat labile toxin; Inadvertent exposure; Oral vaccine; Plant vaccine; Transgenic maize; Transgenic plant

Indexed keywords

BACTERIUM ANTIBODY; ESCHERICHIA COLI ENDOTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; ESCHERICHIA COLI; FECES LEVEL; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; LOW DRUG DOSE; MAIZE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSGENIC PLANT;

ANIMALS; BACTERIAL TOXINS; BRONCHOALVEOLAR LAVAGE FLUID; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED; ZEA MAYS;

ANIMALIA; ESCHERICHIA COLI; MUS; ZEA MAYS;

EID: 34147099174     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9687     Document Type: Article

References (17)

1. Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K. 2002. A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 11:479-493.
2. Chikwamba RK, Scott MP, Mejia LB, Mason HS, Wang K. 2003. Localization of a bacterial protein in starch granules of transgenic maize kernels. Proc Natl Acad Sci USA 101(19): 11127-11132.
3. Karaman S, Cunnick J, Wang K. 2006. Analysis of immune response in young and aged mice vaccinated with maize-derived antigen against Escherichia coli heat-labile enterotoxin. Mol Biotechnol 32(1):31-42.
4. Kirk RE, ed. 1982. Experimental Design. 2nd ed. Monterey, CA: Brooks/ Cole.
5. Kodell RL, Gaylor DW. 1999. Combining uncertainty factors in deriving human exposure levels of noncarcinogenic toxicants. Annals NY Acad Sci 895: 188-195.
6. Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y. 2001, Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 98(20):11539-11544.
7. Lauterslager TGM, Florack DEA, van der Wal TJ, Molthof JW, Langeveld JPM, Bosch D, et al. 2001. Oral immunization of naïve and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19:2749-2755.
8. Ma JKC, Drake PMW, Christou P. 2003. The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794-805.
9. Mason HS, Haq TA, Clements JD, Arntzen CJ. 1998. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16(13):1336-1343.
10. Schmidt CW. 2005. Genetically modified foods: breeding uncertainty. Environ Health Perspect 113:A526-A533.
11. Streatfield SJ, Jilka JM, Hood EE, Turner DD, Bailey MR, Mayor JM, et al. 2001. Plant-based vaccines: unique advantages. Vaccine 19:2742-2748.
12. Tacket CO, 2005. Plant-derived vaccines against diarrheal diseases. Vaccine 23:1866-1869.
13. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ. 1998. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4(5):607-609.
14. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ, 2000. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302-305.
15. Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S, 2004. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic maize. Vaccine 22:4385-4389.
16. Webster DE, Cooney ML, Huang Z, Drew DR, Ramshaw IA, Dry IB et al. 2002. Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine. J Virol 76(15):7910-7912.
17. Wolt JD, Wang K, Peterson RKD, 2006, Assessing risk of unintended antigen occurrence in food: a case instance for maize-expressed LT-B. Hum Ecol Risk Assess 12:856-870.